G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 15,000 shares at $66.67 ($1.0M) on 2019-01-08, disclosed to the SEC on 2019-01-09.
Seasonal sale ($1.0M) by CFO — this insider has traded GHDX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.87 | 2,100 | $138K | 13.8% |
| 2 | $65.90 | 1,100 | $72K | 7.2% |
| 3 | $66.67 | 3,428 | $229K | 22.7% |
| 4 | $66.68 | 1,700 | $113K | 11.3% |
| 5 | $67.85 | 4,472 | $303K | 30.2% |
| 6 | $67.86 | 2,200 |
| $149K |
| 14.8% |
| Total | $67.03 avg | 15,000 | $1.0M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |